Medicines Optimisation Scheme 2020-21

Islington
Add to CPD
Under Review — this page was due to be reviewed by 31/10/2021. The information shown here may be outdated.

Medicines Optimisation Scheme 2020-21

The Islington Medicines Optimisation Scheme (MOS) locally commissioned service for GP practices is designed to run alongside the Quality and Outcomes Framework (QOF) of the General Medical Services (GMS) contract and forms part of practices' Quality, Innovation, Productivity and Prevention (QIPP) plan. 

The MOS invests in and encourages high-quality, safe, clinically effective, cost-efficient, evidence-based prescribing and is intended to support the implementation of national and local guidance.

For more details of this LCS go to the Medicines Management MOS page here.

Specification Document

MOS Scheme 2020/21

DOCX, 1.03 MB

Appendices

LCS Covid-19 guidance (and Q2 payment update)

PDF, 425.23 KB

Islington MOS audit workbook 2020/21

DOCX, 583.85 KB

Overview

Submission
Jan 21st, 2021

Update
Jan 21st, 2021


Last updated: Jan 19th, 2021
Review date: Oct 31st, 2021